title: Large-scale automatic extraction of side effects associated with targeted anticancer drugs from full-text oncological articles.
abstract: Targeted anticancer drugs such as imatinib, trastuzumab and erlotinib dramatically improved treatment outcomes in cancer patients, however, these innovative agents are often associated with unexpected side effects. The pathophysiological mechanisms underlying these side effects are not well understood. The availability of a comprehensive knowledge base of side effects associated with targeted anticancer drugs has the potential to illuminate complex pathways underlying toxicities induced by these innovative drugs. While side effect association knowledge for targeted drugs exists in multiple heterogeneous data sources, published full-text oncological articles represent an important source of pivotal, investigational, and even failed trials in a variety of patient populations. In this study, we present an automatic process to extract targeted anticancer drug-associated side effects (drug-SE pairs) from a large number of high profile full-text oncological articles. We downloaded 13,855 full-text articles from the Journal of Oncology (JCO) published between 1983 and 2013. We developed text classification, relationship extraction, signaling filtering, and signal prioritization algorithms to extract drug-SE pairs from downloaded articles. We extracted a total of 26,264 drug-SE pairs with an average precision of 0.405, a recall of 0.899, and an F1 score of 0.465. We show that side effect knowledge from JCO articles is largely complementary to that from the US Food and Drug Administration (FDA) drug labels. Through integrative correlation analysis, we show that targeted drug-associated side effects positively correlate with their gene targets and disease indications. In conclusion, this unique database that we built from a large number of high-profile oncological articles could facilitate the development of computational models to understand toxic effects associated with targeted anticancer drugs.
authors.affiliation: Medical Informatics Program, Center for Clinical Investigation, Case Western Reserve University, Cleveland, OH 44106, United States. Electronic address: rxx@case.edu.
authors.forename: Rong
authors.initials: R
authors.lastname: Xu
authors.affiliation: ThinTek, LLC, Palo Alto, CA 94306, United States. Electronic address: qwang@thintek.com.
authors.forename: QuanQiu
authors.initials: Q
authors.lastname: Wang
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems / Q000458:organization & administration*; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000145:classification; D057225:Data Mining / Q000379:methods*; D066264:Datasets as Topic / Q000706:statistics & numerical data; D064420:Drug-Related Side Effects and Adverse Reactions / Q000145:classification* / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D000069550:Machine Learning; D058990:Molecular Targeted Therapy / Q000009:adverse effects* / Q000145:classification / Q000706:statistics & numerical data; D009323:Natural Language Processing; D010506:Periodicals as Topic / Q000706:statistics & numerical data*; D018875:Vocabulary, Controlled
chemical_list: D000970:Antineoplastic Agents
keywords: Drug discovery; Drug repositioning; Drug side effects; Drug toxicity prediction; Information extraction; Targeted anticancer drugs; Text mining
references.citation: Clin Pharmacol Ther. 2013 Apr;93(4):335-41
references.pmid: 23443757
references.citation: Sci Transl Med. 2011 Dec 21;3(114):114ra127
references.pmid: 22190238
references.citation: Bioinformatics. 2013 Sep 1;29(17):2186-94
references.pmid: 23828786
references.citation: Sci Transl Med. 2012 Mar 14;4(125):125ra31
references.pmid: 22422992
references.citation: Nat Rev Clin Oncol. 2012 Feb;9(2):98-109
references.pmid: 22182972
references.citation: J Biomed Semantics. 2012 Dec 20;3(1):15
references.pmid: 23256479
references.citation: Cancer. 2012 Apr 1;118(7):1868-76
references.pmid: 21898375
references.citation: Cancer Manag Res. 2010 Jun 01;2:143-56
references.pmid: 21188105
references.citation: J Biomed Inform. 2015 Feb;53:128-35
references.pmid: 25445920
references.citation: Ann Oncol. 2009 May;20 Suppl 1:i7-12
references.pmid: 19430007
references.citation: Circulation. 2008 Jul 1;118(1):84-95
references.pmid: 18591451
references.citation: Cardiovasc Toxicol. 2012 Jun;12(2):93-107
references.pmid: 21894547
references.citation: N Engl J Med. 2005 Oct 20;353(16):1673-84
references.pmid: 16236738
references.citation: Nat Rev Clin Oncol. 2012 Sep;9(9):488
references.pmid: 22850750
references.citation: Nature. 2012 Jun 21;486(7403):361-7
references.pmid: 22722194
references.citation: J Biomed Inform. 2014 Oct;51:191-9
references.pmid: 24928448
references.citation: Nucleic Acids Res. 2004 Jan 1;32(Database issue):D267-70
references.pmid: 14681409
references.citation: Nat Rev Cardiol. 2010 Oct;7(10):564-75
references.pmid: 20842180
references.citation: Nucleic Acids Res. 2008 Jan;36(Database issue):D901-6
references.pmid: 18048412
references.citation: Toxicol Sci. 2011 Mar;120(1):14-32
references.pmid: 21177772
references.citation: Genome Med. 2012 Jan 27;4(1):3
references.pmid: 22283977
references.citation: J Biomed Inform. 2014 Feb;47:171-7
references.pmid: 24177320
references.citation: J Clin Oncol. 2011 Jan 10;29(2):174-85
references.pmid: 21135271
references.citation: BMC Bioinformatics. 2014;15:17
references.pmid: 24428898
references.citation: J Clin Oncol. 2012 Aug 20;30(24):3012-9
references.pmid: 22802313
references.citation: J Am Med Inform Assoc. 2014 Jan-Feb;21(1):90-6
references.pmid: 23686935
references.citation: Drug Saf. 1999 Feb;20(2):109-17
references.pmid: 10082069
references.citation: BMC Bioinformatics. 2014;15:105
references.pmid: 24725842
references.citation: Nat Rev Clin Oncol. 2012 Aug;9(8):471-8
references.pmid: 22751283
references.citation: Clin Cancer Res. 2012 Feb 15;18(4):1120-8
references.pmid: 22223528
references.citation: Eur J Heart Fail. 2011 Jan;13(1):1-10
references.pmid: 21169385
references.citation: N Engl J Med. 2002 Feb 28;346(9):645-52
references.pmid: 11870241
references.citation: Science. 2008 Jul 11;321(5886):263-6
references.pmid: 18621671
references.citation: Clin Cancer Res. 2012 Apr 15;18(8):2316-25
references.pmid: 22261800